BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33007345)

  • 1. Tissue microarray (TMA) use in post mortem neuropathology.
    Wilson LA; Heraty L; Ashford BA; Coelho S; Frangi AF; Pozo JM; Ince PG; Highley JR
    J Neurosci Methods; 2021 Jan; 347():108963. PubMed ID: 33007345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust gridding of TMAs after whole-slide imaging using template matching.
    Lahrmann B; Halama N; Westphal K; Ernst C; Elsawaf Z; Sinn P; Bosch FX; Dickhaus H; Jäger D; Schirmacher P; Grabe N
    Cytometry A; 2010 Dec; 77(12):1169-76. PubMed ID: 20662092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of high-throughput small-core (0.6-mm) and large-core (2-mm) thyroid tissue microarray: is larger better?
    Jones S; Prasad ML
    Arch Pathol Lab Med; 2012 Feb; 136(2):199-203. PubMed ID: 22288969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiographic determination of tissue thickness in paraffin blocks: application to the construction of tissue microarrays.
    Kong X; Zhao Y; Ksionsk M; Zhou M; Walden P; Bosland M; Pei Z; Lee P; Melamed J
    Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):108-12. PubMed ID: 17536317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
    Pedersen MB; Riber-Hansen R; Nielsen PS; Bendix K; Hamilton-Dutoit SJ; D'Amore F; Steiniche T
    Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):577-84. PubMed ID: 24897068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Andersen J; Overgaard J
    Acta Oncol; 2008; 47(4):591-9. PubMed ID: 18465327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a tissue microarray with two millimeters cores of endometrioid endometrial cancer: factors affecting the quality of the recipient block.
    Gottwald L; Sęk P; Piekarski J; Pasz-Walczak G; Kubiak R; Szwalski J; Spych M; Suzin J; Tyliński W; Topczewska-Tylinska K; Jeziorski A
    Biotech Histochem; 2012 Nov; 87(8):512-8. PubMed ID: 22909182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer.
    Visser NCM; van der Wurff AAM; Pijnenborg JMA; Massuger LFAG; Bulten J; Nagtegaal ID
    Virchows Arch; 2018 Mar; 472(3):407-413. PubMed ID: 29426961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-house Manual Construction of High-Density and High-Quality Tissue Microarrays by Using Homemade Recipient Agarose-Paraffin Blocks.
    Kim KH; Choi SJ; Choi YI; Kim L; Park IS; Han JY; Kim JM; Chu YC
    Korean J Pathol; 2013 Jun; 47(3):238-44. PubMed ID: 23837016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of tissue microarrays using pre-existing slides as source of tissue when paraffin blocks are unavailable.
    Deng FM; Zhao Y; Kong X; Lee P; Melamed J
    J Clin Pathol; 2013 Jul; 66(7):627-9. PubMed ID: 23476078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tissue microarray technology for analyses of gene expression in frozen pathological samples.
    Zhou L; Hodeib M; Abad JD; Mendoza L; Kore AR; Hu Z
    Biotechniques; 2007 Jul; 43(1):101-5. PubMed ID: 17695259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
    Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
    J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma.
    Bhargava R; Lal P; Chen B
    Diagn Mol Pathol; 2004 Dec; 13(4):213-6. PubMed ID: 15538111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?
    Anagnostou VK; Lowery FJ; Syrigos KN; Cagle PT; Rimm DL
    Arch Pathol Lab Med; 2010 Apr; 134(4):613-9. PubMed ID: 20367312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tissue micro-array data exchange specification: a web based experience browsing imported data.
    Nohle DG; Hackman BA; Ayers LW
    BMC Med Inform Decis Mak; 2005 Aug; 5():25. PubMed ID: 16086837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of high-density tissue microarrays at low cost by using self-made manual microarray kits and recipient paraffin blocks.
    Choi CH; Kim KH; Song JY; Choi SJ; Kim L; Park IS; Han JY; Kim JM; Chu YC
    Korean J Pathol; 2012 Dec; 46(6):562-8. PubMed ID: 23323107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.
    Berlth F; Mönig SP; Schlösser HA; Maus M; Baltin CT; Urbanski A; Drebber U; Bollschweiler E; Hölscher AH; Alakus H
    Anticancer Res; 2014 Jul; 34(7):3313-20. PubMed ID: 24982335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ.
    Quintayo MA; Starczynski J; Yan FJ; Wedad H; Nofech-Mozes S; Rakovitch E; Bartlett JM
    Histopathology; 2014 Jul; 65(1):2-8. PubMed ID: 24267587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and validation of epithelial recognition and fields of view algorithms on virtual slides to guide TMA construction.
    Barsky S; Gentchev L; Basu A; Jimenez R; Boussaid K; Gholap A
    Biotechniques; 2009 Nov; 47(5):927-38. PubMed ID: 20041846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue microarrays for routine diagnostic assessment of HER2 status in breast carcinoma.
    Drev P; Grazio SF; Bracko M
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):179-84. PubMed ID: 18227723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.